Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHI-IMD: Immune-based Therapy for Primary HIV Infection
NCT00979706Phase 4Completed
- Start
- Mar 2005
- Primary completion
- Nov 2014
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine, sargramostim, peginterferon alfa-2b, aldesleukin in human immunodeficiency virus infection (HIV). Started Mar 2005; status: completed.
02
Drugs
cyclosporinesargramostimpeginterferon alfa-2baldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00979706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979706.